Business

Amplia targets ovarian cancer in new clinical protein inhibitor trial

1 hour ago5 views0

Amplia Therapeutics is launching a new clinical trial of its protein inhibitor drug narmafotinib in ovarian cancer, partnering with research group ANZGOG.

Business / Companies

Brisbane Times – Business

ASX set to fall as Wall Street retreats from records

The US stock market is hanging just below its records while oil prices keep dropping ...

10 hours ago

Business

Why did my workplace agree to an idea we knew would fail?

Rather than dwelling too much on the bad idea itself, it might be better to ...

10 hours ago

Business

Michele Bullock has made a bold move – and it’s not the rate rise

The RBA governor is careful not to make her predecessor’s mistakes. But she’s changed her ...

10 hours ago

Now Reading

Amplia targets ovarian cancer in new clinical protein inhibitor trial

1min read

0 %

Amplia targets ovarian cancer in new clinical protein inhibitor trial

Murder charges laid in search for missing Queensland man

Leave a reply Cancel reply

More in:Business

ASX set to fall as Wall Street retreats from records

Why did my workplace agree to an idea we knew would fail?

Michele Bullock has made a bold move – and it’s not the rate rise

Posts List

Points! Status! Virgin, Qantas woo travellers with loyalty deals

‘Have you seen the share price!?’ Controversial AI founder slams short attack

Lindian powers towards rare earths production lift off in Malawi

Categories

The Inland Report

Share

You may also like

Leave a reply Cancel reply

More in:Business

Posts List

Categories

Latest Posts